Page 2 - Institute For Liver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dry January: What is Dry January and how beneficial can giving up alcohol be?

Dry January, i.e. having no alcohol for the entire month, is one resolution that might actually make you healthier.

United kingdomUnited statesUs national institute on alcohol abuseMental health services administrationNational institute of alcohol abuseCenters for diseaseAmerican psychological associationUniversity college london medical schoolUniversity of north carolina at chapel hillHealth psychologyInstitute for liverDigestive healthPublic health englandNew yearDry januaryNew scientist

Why Dry January is so good for you - including lower risk of cancer and better skin

Why Dry January is so good for you - including lower risk of cancer and better skin
walesonline.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from walesonline.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomHeidi karGautam mehtaEric collinsHeather martinK health primary care programInstitute for liverDigestive healthNational institute on alcohol abuseDry januaryAlcohol change united kingdomRecovery educationApplied learningNational instituteAlcohol abuse

Pros and cons of giving up alcohol

The latest Pros And Cons,/pros-and-cons,,pros-and-cons, breaking news, comment, reviews and features from the experts at The Week

United kingdomEast sussexGautam mehtaRichard piperMen healthInstitute for liverUniversity of sussexUniversity of yorkBritish liverDigestive healthDry januaryGood news newsletterIan hamiltonAlcohol change united kingdom

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare.

Barbara lindheimWadi morRaanan greenmanRifaat safadiAvi katavJohn lawlerHomer leviDouglas thorburnChris cirilloIrina kofflerMatthew frankelShelia sherlockTom snirChristopher bowlusIlan vakninMassimo pinzani

Novel liver dialysis device yields rapid clinical effect in patients with liver failure

The Dialive device significantly reduced severity of endotoxemia and improved albumin function in patients with acute-on-chronic liver failure and appears safe with careful patient monitoring, according to data in the Journal of Hepatology. “Dialive is a novel liver dialysis device invented at University College London,” Rajiv Jalan, PhD, lead investigator and professor of hepatology

Rajiv jalanSteffen mitznerDigestive healthRostock university medical centerUniversity college londonInstitute for liverChronic liver failure